Cargando…

Systems pharmacogenomics identifies novel targets and clinically actionable therapeutics for medulloblastoma

BACKGROUND: Medulloblastoma (MB) is the most common malignant paediatric brain tumour and a leading cause of cancer-related mortality and morbidity. Existing treatment protocols are aggressive in nature resulting in significant neurological, intellectual and physical disabilities for the children un...

Descripción completa

Detalles Bibliográficos
Autores principales:	Genovesi, Laura A., Millar, Amanda, Tolson, Elissa, Singleton, Matthew, Hassall, Emily, Kojic, Marija, Brighi, Caterina, Girard, Emily, Andradas, Clara, Kuchibhotla, Mani, Bhuva, Dharmesh D., Endersby, Raelene, Gottardo, Nicholas G., Bernard, Anne, Adolphe, Christelle, Olson, James M., Taylor, Michael D., Davis, Melissa J., Wainwright, Brandon J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8215804/ https://www.ncbi.nlm.nih.gov/pubmed/34154646 http://dx.doi.org/10.1186/s13073-021-00920-z

Ejemplares similares

MOMC-5. Systems pharmacogenomics identifies novel targets and clinically actionable therapeutics for medulloblastoma
por: Genovesi, Laura, et al.
Publicado: (2021)

Spatial transcriptomic analysis of Sonic hedgehog medulloblastoma identifies that the loss of heterogeneity and promotion of differentiation underlies the response to CDK4/6 inhibition
por: Vo, Tuan, et al.
Publicado: (2023)

MEDB-06. Spatial transcriptomic analysis of Sonic Hedgehog Medulloblastoma identifies that loss of heterogeneity and induced differentiation underlies the response to CDK4/6 inhibition
por: Vo, Tuan, et al.
Publicado: (2022)

BIOL-12. ENHANCING IMMUNE-MEDIATED TUMOR CONTROL IN MURINE MODELS OF GROUP 3 MEDULLOBLASTOMA
por: Abbas, Zahra, et al.
Publicado: (2023)

Assessment of Cannabidiol and Δ9-Tetrahydrocannabiol in Mouse Models of Medulloblastoma and Ependymoma
por: Andradas, Clara, et al.
Publicado: (2021)

Veliparib Is an Effective Radiosensitizing Agent in a Preclinical Model of Medulloblastoma
por: Buck, Jessica, et al.
Publicado: (2021)

Conventional Therapies Deplete Brain-Infiltrating Adaptive Immune Cells in a Mouse Model of Group 3 Medulloblastoma Implicating Myeloid Cells as Favorable Immunotherapy Targets
por: Abbas, Zahra, et al.
Publicado: (2022)

A Novel Orthotopic Patient-Derived Xenograft Model of Radiation-Induced Glioma Following Medulloblastoma
por: Whitehouse, Jacqueline P., et al.
Publicado: (2020)

Editorial: Bench to bedside: translating pre-clinical research into clinical trials for childhood brain tumors
por: Endersby, Raelene, et al.
Publicado: (2023)

The Role of Cannabinoids as Anticancer Agents in Pediatric Oncology
por: Andradas, Clara, et al.
Publicado: (2021)

Genetic and functional interaction network analysis reveals global enrichment of regulatory T cell genes influencing basal cell carcinoma susceptibility
por: Adolphe, Christelle, et al.
Publicado: (2021)

Medulloblastoma Down Under 2013: a report from the third annual meeting of the International Medulloblastoma Working Group
por: Gottardo, Nicholas G., et al.
Publicado: (2013)

RONC-07. Fractionated radiotherapy is required to accurately mimic neurostructural late effects in preclinical models
por: Whitehouse, Jacqueline, et al.
Publicado: (2022)

MDB-42. UNCOVERING DYNAMIC CHANGES IN MEDULLOBLASTOMA ASSOCIATED VASCULATURE IN ZEBRAFISH
por: Morris, Elysse, et al.
Publicado: (2023)

Defining the molecular features of radiation-induced glioma: A systematic review and meta-analysis
por: Whitehouse, Jacqueline P, et al.
Publicado: (2021)

Integrated Analysis of miRNA and mRNA Expression in Childhood Medulloblastoma Compared with Neural Stem Cells
por: Genovesi, Laura A., et al.
Publicado: (2011)

A Pre-Clinical Assessment of the Pan-ERBB Inhibitor Dacomitinib in Pediatric and Adult Brain Tumors
por: Endersby, Raelene, et al.
Publicado: (2018)

MR-guided focused ultrasound increases antibody delivery to nonenhancing high-grade glioma
por: Brighi, Caterina, et al.
Publicado: (2020)

Comparative study of preclinical mouse models of high-grade glioma for nanomedicine research: the importance of reproducing blood-brain barrier heterogeneity
por: Brighi, Caterina, et al.
Publicado: (2020)

A novel technique of serial biopsy in mouse brain tumour models
por: Rogers, Sasha, et al.
Publicado: (2017)

Elongator mutation in mice induces neurodegeneration and ataxia-like behavior
por: Kojic, Marija, et al.
Publicado: (2018)

RONC-02. MEASURING THE EFFECT OF CLINICALLY-RELEVANT RADIOTHERAPY PROTOCOLS ON THE JUVENILE MOUSE BRAIN
por: Buck, Jessica, et al.
Publicado: (2020)

Efficient detection and monitoring of pediatric brain malignancies with liquid biopsy based on patient-specific somatic mutation screening
por: Kojic, Marija, et al.
Publicado: (2023)

MBRS-24. FUNCTIONAL CHARACTERIZATION OF IKBKAP/ELP1 AS A NOVEL SHH MEDULLOBLASTOMA PREDISPOSITION GENE
por: Lopez, Jesus Garcia, et al.
Publicado: (2020)

MBCL-21. GERMLINE ELONGATOR MUTATIONS IN SONIC HEDGEHOG MEDULLOBLASTOMA
por: Robinson, Giles W, et al.
Publicado: (2020)

Genetic alterations of TP53 and OTX2 indicate increased risk of relapse in WNT medulloblastomas: “it’s a numbers game”—implications for WNT medulloblastoma dose-reduction clinical trials
por: Gottardo, Nicholas G.
Publicado: (2022)

Vincristine-induced peripheral neuropathy is driven by canonical NLRP3 activation and IL-1β release
por: Starobova, Hana, et al.
Publicado: (2021)

Stable gene expression for normalisation and single-sample scoring
por: Bhuva, Dharmesh D, et al.
Publicado: (2020)

The Many Faces of Elongator in Neurodevelopment and Disease
por: Kojic, Marija, et al.
Publicado: (2016)

Chemotherapy-induced peripheral neuropathy in children and adolescent cancer patients
por: Tay, Nicolette, et al.
Publicado: (2022)

Pharmacogenomics
Publicado: (2008)

Pharmacogenomics
Publicado: (2008)

Design Recommendations for Pharmacogenomics Clinical Decision Support Systems
por: Khelifi, Maher, et al.
Publicado: (2017)

High-Dose Chemotherapy in Children with Newly Diagnosed Medulloblastoma
por: Lafay-Cousin, Lucie, et al.
Publicado: (2022)

DIPG-50. A NOVEL ORTHOTOPIC PATIENT-DERIVED XENOGRAFT MODEL OF RADIATION-INDUCED GLIOMA
por: Whitehouse, Jacqueline, et al.
Publicado: (2020)

Clinical evidence for synergy between immunotherapy and radiotherapy (SITAR)
por: Gill, Suki, et al.
Publicado: (2022)

ABC transporter activity linked to radiation resistance and molecular subtype in pediatric medulloblastoma
por: Ingram, Wendy J, et al.
Publicado: (2013)

An assessment of patient perspectives on pharmacogenomics educational materials
por: Asiedu, Gladys B, et al.
Publicado: (2020)

Pharmacogenomics arrives
por: Petsko, Gregory A
Publicado: (2004)

Pharmacogenomic Biomarkers
por: Kirkwood, Sandra C., et al.
Publicado: (2002)

Cannot write session to /tmp/vufind_sessions/sess_2uid9o1jnhot1smc53ojmv9vfd